The Latest from Rahila Zakir

I am delighted to continue the care of all patients who have been looked after by Mr Edmund Schulenburg, who has now retired. I realise that changing doctors can be a time of uncertainty...

Rahila Zakir and a team of junior doctors presented a poster of their early results with real world use of Jetrea (Ocriplasmin) for macular holes and vitreomacular traction at EURETINA,...

Rahila presents the ‘The INJECT study: a non-interventional, multi-centre, worldwide study in patients treated with JETREA’ at ISOPT, The International Symposium on Ocular Pharmacology...

Rahila Zakir is Principal Investigator for the INJECT trial at Imperial College London and we start recruiting patients for an observational trial of Jetrea (Ocriplasmin) in...

Rahila shared her experience of setting up a Jetrea (Ocriplasmin) injection service for vitreomacular traction and macular holes at the Mecical EducTion Event, JETREA® (ocriplasmin)...

Rahila supervised a foundation year doctor with an interest in ophthalmology and a team of ophthalmology trainees to present their study of Open Globe Injuries in West London. The...

Rahila Zakir gave a lecture giving an update of vitreoretinal conditions at the Staff and Associate Specialists Study Day, with some excellent feedback:- 75 delegates provided feedback...

Rahila Zakir submitted a new drugs application for Jetrea for the treatment of macular holes and vitreomacular traction, and this is now available for use in the NHS for North West...